Newsletter Xagena

Search results for "Adalimumab"

Corticosteroids are the mainstay of treatment for immune-mediated diseases, including non-infectious uveitis and ocular inflammation, because they are inexpensive, potent and rapidly effective. Howeve ...

All three commonly used TNF blockers ( Infliximab, Etanercept and Adalimumab ) were initially approved for the treatment of rheumatoid arthritis, and were subsequently approved for a number of other s ...

A new study published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus ( AAPOS ) suggests that the biologic agent Adalimumab ( Humira ) may be a viable treatment o ...

A study has assessed the safety and efficacy of Tocilizumab ( Actemra; RoActemra ) in patients with severe and refractory non-infectious uveitis.
Eight consecutive unselected patients with severe a ...

Tumour necrosis factor ( TNF ) blockers have been demonstrated to be effective in the treatment of systemic and ocular inflammatory diseases.
Researchers have conducted a prospective, multicentre, o ...

The aim of a study was to assess the efficacy of Adalimumab ( Humira ) in patients with active non-infectious uveitis in three different centres.
In a retrospective study researchers have identifie ...